PER 1.41% 7.0¢ percheron therapeutics limited

Ann: Phase II DMD clinical trial on track for dosing completion, page-21

  1. 4,103 Posts.
    lightbulb Created with Sketch. 1866
    They are putting the word out there

    https://biotechdispatch.com.au/news/antisense-therapeutics-updates-on-atl1102-trial-1

    Actually if we count back 12 wks from projected early November trial completion

    It brings us back to early August so who knows

    As Monty says things could just start warming

    I know some will chuckle but the chart has turned and it has a distance to travel from way oversold just a need some volume to confirm

    See how we go
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.